http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106511498-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106511498-B |
| titleOfInvention | Pharmaceutical composition for treating gout and bone diseases |
| abstract | The invention discloses a pharmaceutical composition for treating gout and bone diseases, which belongs to the technical field of medicines and comprises the following components in parts by weight: 35-38 parts of semen plantaginis, 10-14 parts of astragalus membranaceus, 10-14 parts of pseudo-ginseng, 10-14 parts of rheum officinale, 10-14 parts of liquorice and 10-14 parts of honeysuckle; the traditional Chinese medicine composition is relatively simple in components, the components are common traditional Chinese medicines without toxic and side effects, the safety is high, no toxic and side effects exist after the mouse experiment is carried out for 1 month, and no toxic and side effects exist after the mouse composition is clinically used for 2 months; the curative effect is exact, the effective rate for treating gout reaches 96.7%, and the cure rate can reach 85.6%. |
| priorityDate | 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.